Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-31 @ 10:54 PM
Study NCT ID:
NCT06670105
Status:
WITHDRAWN
Last Update Posted:
2025-09-17
First Post:
2024-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-01-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-01-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-31
First Submit QC Date:
None
Study First Post Date:
2024-11-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-09-17
Last Update Post Date Type:
ESTIMATED